Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02055742 · ClinicalTrials.gov registry record
Detection of Chlamydia (CT) and Gonorrhea (NG)
A clinical trial, sponsored by Meridian Bioscience.
- Completed
- Registry status
- 700
- Enrollment target
NCT02055742 is a clinical trial that has completed, run by Meridian Bioscience. The registered enrollment target is 700 participants.
The verdict
NCT02055742 has completed, sponsored by Meridian Bioscience.
- COMPLETED
- Registry status
- 700 participants
- Enrollment target
Study Summary
To evaluate the illumigene Chlamydia and illumigene Gonorrhea assays, using the illumipro-10, with male urine, female urine, physician-collected (medical professional) endocervical swabs and self-collected vaginal swabs taken from symptomatic and asymptomatic patient populations.
Interventions
- DEVICE illumigene CT and NG assays, illumipro-10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2014-03-01 |
| Est. Completion | 2014-09-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02055742
The ClinicalTrials.gov registry entry for NCT02055742 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meridian Bioscience, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which illumigene CT and NG assays, illumipro-10 is the first listed.
NCT02055742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02055742 about?
NCT02055742 is a clinical study titled "Detection of Chlamydia (CT) and Gonorrhea (NG)". To evaluate the illumigene Chlamydia and illumigene Gonorrhea assays, using the illumipro-10, with male urine, female urine, physician-collected (medical professional) endocervical swabs and self-collected vaginal swabs taken from symptomatic and asymptomatic patient populations.
What is the current status of trial NCT02055742?
This trial is currently completed. The enrollment target is 700 participants. The study started on 2014-03-01. Estimated completion is 2014-09-09.
What interventions are being tested in trial NCT02055742?
The interventions under investigation include: illumigene CT and NG assays, illumipro-10 (DEVICE).
Who is sponsoring clinical trial NCT02055742?
This trial is sponsored by Meridian Bioscience, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.